Literature DB >> 11314769

Dopaminergic mRNA expression in the intact substantia nigra of unilaterally 6-OHDA-lesioned and grafted rats: an in situ hybridization study.

N Drandarevski1, A Marburger, D Walther, T Reum, G Uh, R Morgenstern.   

Abstract

The present study was performed to investigate the influence of intrastriatal fetal mesencephalic grafts on dopaminergic mRNA expression in the non-lesioned substantia nigra pars compacta of unilaterally 6-hydroxydopamine-lesioned rats. The expression of dopamine transporter mRNA, synaptic vesicular monoamine transporter mRNA and tyrosine hydroxylase mRNA was assessed in adjacent cryostat sections using in situ hybridization. Rotational behavior induced by apomorphine and amphetamine as well as hybridization of striatal sections cut at the grafting coordinates were used to prove the functional recovery and the presence of grafted cells, respectively. After grafting, the number of rotations was decreased and hybridization signals overlying cells in the grafted striatum were detected. Mean grain densities overlying labeled neurons in the substantia nigra pars compacta of grafted rats were compared to those of shamgrafted rats and revealed differential expression of dopamine transporter mRNA, whereas synaptic vesicular monoamine transporter mRNA and tyrosine hydroxylase mRNA expression showed no difference. The results will be discussed in relation to previous in vitro and in vivo studies suggesting a reduction of functional dopamine transporter molecules in the contralateral striatum.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11314769     DOI: 10.1007/s007020170084

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  41 in total

1.  Reconstruction of the nigrostriatal dopamine pathway by intracerebral nigral transplants.

Authors:  A Björklund; U Stenevi
Journal:  Brain Res       Date:  1979-11-30       Impact factor: 3.252

2.  Complete coding sequence of rat tyrosine hydroxylase mRNA.

Authors:  B Grima; A Lamouroux; F Blanot; N F Biguet; J Mallet
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

3.  Interdependence of the nigrostriatal dopaminergic systems on the two sides of the brain in the cat.

Authors:  A Nieoullon; A Cheramy; J Glowinski
Journal:  Science       Date:  1977-10-28       Impact factor: 47.728

4.  Time-course of recovery of dopamine neuron activity during reinnervation of the denervated striatum by fetal mesencephalic grafts as assessed by in vivo voltammetry.

Authors:  C Forni; P Brundin; R E Strecker; S el Ganouni; A Björklund; A Nieoullon
Journal:  Exp Brain Res       Date:  1989       Impact factor: 1.972

5.  Dopamine transporter mRNA: dense expression in ventral midbrain neurons.

Authors:  S Shimada; S Kitayama; D Walther; G Uhl
Journal:  Brain Res Mol Brain Res       Date:  1992-05

6.  In vivo measurement of spontaneous release and metabolism of dopamine from intrastriatal nigral grafts using intracerebral dialysis.

Authors:  T Zetterström; P Brundin; F H Gage; T Sharp; O Isacson; S B Dunnett; U Ungerstedt; A Björklund
Journal:  Brain Res       Date:  1986-01-08       Impact factor: 3.252

Review 7.  Molecular, functional and biochemical characteristics of the dopamine transporter: regional differences and clinical relevance.

Authors:  A Hitri; Y L Hurd; R J Wyatt; S I Deutsch
Journal:  Clin Neuropharmacol       Date:  1994-02       Impact factor: 1.592

8.  Transcriptional regulation of the tyrosine hydroxylase gene by glucocorticoid and cyclic AMP.

Authors:  E J Lewis; C A Harrington; D M Chikaraishi
Journal:  Proc Natl Acad Sci U S A       Date:  1987-06       Impact factor: 11.205

9.  Identification of cDNA clones coding for rat tyrosine hydroxylase antigen.

Authors:  A Lamouroux; N Faucon Biguet; D Samolyk; A Privat; J C Salomon; J F Pujol; J Mallet
Journal:  Proc Natl Acad Sci U S A       Date:  1982-06       Impact factor: 11.205

10.  Grafts modulate dopamine transporters of the non-lesioned striatum.

Authors:  U Schäfer; T Reum; D Schönfuss; A Marburger; R Morgenstern
Journal:  Neuroreport       Date:  1995-10-02       Impact factor: 1.837

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.